Clinical Trial Update: Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder [Phase 2]

View source ↗

Summary

Phase 2 study validating the IDSIQ questionnaire in patients with insomnia disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia Disorder

Drugs mentioned

• IDSIQ

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Insomnia Disorder | Phase 2 | Status: COMPLETED